Skip to main content
Market intelligence
INBXHealthcare

Inhibrx Inc insider activity

In the last 90 days, 3 corporate insiders purchased $6,347,358 of stock on the open market.

SEC-reported filing activity is provided for research purposes and is not investment advice.

90-day C-suite buyers
1
90-day purchase value
$6,347,358
Corporate buyers
3
Latest transaction
Oct 14, 2026

Executive filings

Open-market transaction history

Purchase and sale summaries are ordered by the latest reported transaction date.

Open-market insider purchase and sale transactions
DateInsider nameRoleTypeSharesPriceTotal value
Oct 14, 2026Mark LappeChief Executive OfficerOpen Market Purchase10,040$84.56$848,976
Sep 28, 2026Mark LappeChief Executive OfficerOpen Market Purchase10,000$99.88$998,784
Sep 23, 2026Jon Faiz KayyemCorporate insiderOpen Market Purchase5,000$100.00$500,000